We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > oseltamivir

News List

A Better Anti-Influenza Solution: Roche’s Blockbuster New Drug Applied for Marketing in China PharmaSources/Xiaoyaowan
June 24, 2020
According to the website of the CDE on June 10, the marketing applications of Roche for its new drug Baloxavir Marboxil Tablets in China have been accepted by the CDE.
Hetero and Shenzhen Beimei Pharmaceuticals launch antiviral drug Oselavir® in China prnasia
November 12, 2021
Hetero, a globally renowned vertically integrated pharmaceutical organization and Shenzhen Beimei Pharmaceuticals jointly announced that they have received import drug license...
Immunic Begins IMU-838, Oseltamivir Trial for COVID-19 americanpharmaceuticalreview
July 31, 2020
Immunic announced enrollment of the first patients in an investigator-sponsored phase 2 clinical trial of the company's selective oral DHODH inhibitor, IMU-838, for the treatment of patients with coronavirus disease 2019 (COVID-19).
Roche unveils PhIII data for flu drug pharmatimes
October 11, 2018
Roche has unveiled late-stage data showing that its experimental antivrial drug baloxavir marboxil hit efficacy and safety targets in patients with flu.